Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats.
about
Effects of the blood coagulation vitamin K as an inhibitor of arterial calcificationThe health benefits of vitamin KVitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype.Association of warfarin use with valvular and vascular calcification: a review.Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients.The vitamin K cycle.Functional study of the vitamin K cycle in mammalian cells.Gla-rich protein is a novel vitamin K-dependent protein present in serum that accumulates at sites of pathological calcifications.Vitamin K does not prevent soft tissue mineralization in a mouse model of pseudoxanthoma elasticum.Administration of vitamin K does not counteract the ectopic mineralization of connective tissues in Abcc6 (-/-) mice, a model for pseudoxanthoma elasticum.A review of the effect of diet on cardiovascular calcification.High-Dose Menaquinone-7 Supplementation Reduces Cardiovascular Calcification in a Murine Model of Extraosseous Calcification.Transglutaminase 2-mediated activation of β-catenin signaling has a critical role in warfarin-induced vascular calcificationVitamin K: an old vitamin in a new perspective.Mechanisms and clinical consequences of vascular calcificationThe immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability?Characterization of vitamin K-dependent carboxylase mutations that cause bleeding and nonbleeding disorders.The role of vitamin K in soft-tissue calcification.Vitamin K-dependent proteins, warfarin, and vascular calcificationVitamin K status in chronic kidney disease.Crosstalk between Vitamins A, B12, D, K, C, and E Status and Arterial Stiffness.Vascular calcification: an update on mechanisms and challenges in treatmentThe role of menaquinones (vitamin K₂) in human health.Vitamin K and musculoskeletal health in postmenopausal women.Public health relevance of drug-nutrition interactions.Vitamin K supplementation increases vitamin K tissue levels but fails to counteract ectopic calcification in a mouse model for pseudoxanthoma elasticum.Canola and hydrogenated soybean oils accelerate ectopic bone formation induced by implantation of bone morphogenetic protein in miceUndercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation index.Vitamin K2 added for nutritional purposes in foods for particular nutritional uses, food supplements and foods intended for the general population and Vitamin K2 as a source of vitamin K added for nutritional purposes to foodstuffs, in the context...Scientific Opinion on the substantiation of a health claim related to vitamin K2 and contribution to the normal function of the heart and blood vessels (ID 125, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006Flavonoids, Dairy Foods, and Cardiovascular and Metabolic Health: A Review of Emerging Biologic Pathways.Missense mutation of VKORC1 leads to medial arterial calcification in ratsVascular calcification and renal bone disorders
P2860
Q24654794-0E9CDA82-F600-4EED-B8AA-1553209F1486Q26782816-1CFA26FB-3745-4358-BD99-E2976406C446Q34033497-EB7ABDC4-469C-4631-997F-7204F5CFA332Q34162996-C9DE7E5D-7DF2-44A7-B261-2E1169F2E182Q34241519-6C6113EB-170A-4370-A474-55AA20D03A27Q34443182-AF205875-29C9-4749-AA4A-F542DDCAC5C9Q34707195-812966DC-3CC5-43D8-8E71-0C22278AC750Q35011509-6B8739DC-6490-4C81-BC44-97A5B696E06DQ35124608-4F42E462-3676-4867-BF12-933AD569C3E1Q35215438-53D0E466-C9DD-450F-AF2A-3BAE55A47328Q35585755-4E6D32DF-AAF0-4F72-859F-FEF63587F63EQ35752060-6955FF6E-5788-483E-87E8-53100F40306CQ36029304-42CEDCCE-1E66-42C9-BD03-66D23C20C91BQ36085986-330E8345-B37B-4B99-96FC-7242E1506AD7Q36142207-BDB93EFC-9C17-4E74-B861-009867F2D720Q36470227-A218BE00-C216-4713-91F1-93C50B01A03BQ36800446-597AD224-FBDE-47BB-97B1-8B9ABF4F8633Q36828721-74113DC4-BB92-4A59-9472-157D92CD967EQ37170124-D350A305-EFA6-46E1-A57B-208CA4022307Q37357929-8365458D-19CF-47FC-AB15-77269FFB105CQ37607403-8C5F453F-5B2C-435D-84C6-1BE97079BF5BQ38086058-5FA655A8-72AF-43A4-ADA2-9C23025EFCBFQ38099442-011726DA-6FDA-4AE1-B860-C2293231D594Q38222552-76495EAB-596C-4A33-80DD-B9E4D1812431Q38651214-C2FECC86-169D-43D9-BF7F-6886DBEF267EQ38729250-A5D162F7-02BA-4278-905A-CB2360DA2111Q41680932-421EA0A4-08B8-443E-BDE5-BF57F51D6AFAQ46279181-E4B64CCA-A5BD-4B4A-ABBD-A784960E8009Q47145942-6BB28044-9D98-4C63-9B94-002338013642Q47151838-333C0780-68AD-4345-A16B-1599F74B422EQ49953600-398B544C-59B9-45D0-9DB5-053B840B8B79Q58743826-3CFF0049-7CBE-4C25-9E67-7A3404B950C5Q59100578-CD7BEAA3-0D7A-485A-B560-096D7C8179A3
P2860
Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Tissue-specific utilization of ...... tion in warfarin-treated rats.
@ast
Tissue-specific utilization of ...... tion in warfarin-treated rats.
@en
Tissue-specific utilization of ...... tion in warfarin-treated rats.
@nl
type
label
Tissue-specific utilization of ...... tion in warfarin-treated rats.
@ast
Tissue-specific utilization of ...... tion in warfarin-treated rats.
@en
Tissue-specific utilization of ...... tion in warfarin-treated rats.
@nl
prefLabel
Tissue-specific utilization of ...... tion in warfarin-treated rats.
@ast
Tissue-specific utilization of ...... tion in warfarin-treated rats.
@en
Tissue-specific utilization of ...... tion in warfarin-treated rats.
@nl
P2093
P356
P1476
Tissue-specific utilization of ...... ation in warfarin-treated rats
@en
P2093
B A M Soute
H H W Thijssen
H M H Spronk
J G R De Mey
L J Schurgers
P304
P356
10.1159/000075344
P50
P577
2003-11-01T00:00:00Z